Johnson & Johnson and partner Sanofi will stop a late-stage trial of an experimental vaccine to prevent infections caused by ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Sanofi (SNYNF – Research Report) and Fate ...

On an adjusted basis, Biogen expects 2025 profit between $15.25 and $16.25 per share. It earned $16.47 in 2024 and analysts ...

(Reuters) - Johnson & Johnson said on Thursday it will discontinue a late-stage study of an experimental E.coli vaccine it was developing in partnership with Sanofi.

Sanofi Consumer Healthcare India Ltd share price was down by -0.10% from the previous closing price of ₹4,706.55. Who are peers of Sanofi Consumer Healthcare India Ltd? The peers of Sanofi ...

Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, pursuant to a Certificate of Incorporation, issued by the Registrar of Companies, Central Registration Centre.

Sanofi is following in the footsteps of a number of its peers in pharma with a plan to spin off its consumer health business into a separate company and focus its efforts on its prescription drugs ...

Sanofi has moved ahead with plans to challenge ... which remains a major public health issue worldwide, with the first subject dosed last week. At the moment, Pfizer's Prevnar franchise dominates ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Sanofi Healthcare India has announced a significant milestone ... This complication originates from allogeneic stem cell transplantation, leading to serious health issues. (With inputs from agencies.) ...